Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

Pharma manufacturing news in brief

August 20, 2012
Manufacturing and Production, Sales and Marketing Cambrex, GSK, Laureate, Morphotek

GlaxoSmithKline says it has shut down one of its two manufacturing facilities in India after offering all workers there early …

News

GSK severe asthma drug progresses to Phase III

August 20, 2012
Research and Development, Sales and Marketing Advair, GSK, Phase II, asthma, phase III

GlaxoSmithKline’s severe asthma drug mepolizumab has impressed in a mid-stage study, meaning it can now progress into Phase III testing. …

News
GSK HQ

GSK sheds Australian generics unit for £172m

August 15, 2012
Sales and Marketing Aspen Global, GSK, generics

GlaxoSmithKline has divested the majority of its Australian generics unit to Aspen Global, a firm it partly owns. The South …

News

Pfizer pays $60m in bribery cases

August 8, 2012
Sales and Marketing DoJ, FDA, GSK, Janssen, Pfizer, Wyeth, bribery

Pfizer has been fined $60 million for making improper payments to doctors in Europe, Asia and the Middle East. The …

News

GSK’s Votrient gains new licence

August 8, 2012
Sales and Marketing GSK, NICE, Votrient, soft cell sarcoma

GlaxoSmithKline has gained a new European licence for its cancer pill Votrient adding to its renal cell carcinoma licence. The …

News
GSK image

GSK submits melanoma drugs for regulatory approval

August 3, 2012
Sales and Marketing FDA, GSK, NDA, Zelboraf, melanoma, oncology

GlaxoSmithKline has submitted its two investigational melanoma drugs to regulators in both Europe and the US. The firm is seeking …

News

Olympics to kick-start research ventures

August 1, 2012
Research and Development, Sales and Marketing GSK, London 2012, Olympics, research

London 2012 could provide a boost in the continuing search for personalised medicines for diabetes, heart disease and dementia as …

News

GSK falters in Q2 as austerity measures bite

July 25, 2012
Sales and Marketing Benylsta, GSK, Q2, Seretide, Witty

GlaxoSmithKline posted a loss in its second quarter results, as pressure in mature markets continues to affect the firm. Pharmaceutical …

News
gsk image

GSK raises stake in Amicus for Fabry drug

July 18, 2012
Research and Development, Sales and Marketing Amicus, Fabry, GSK, R&D

GlaxoSmithKline is to increase ownership in Amicus Therapeutics as the firms extend their collaboration to find a new drug for …

News
Human Genome Sciences image

Glaxo seals $3 billion acquisition of HGS

July 17, 2012
Business Services, Research and Development, Sales and Marketing Benlysta, GSK, Human Genome Sciences, R&D

GlaxoSmithKline has finally sealed the acquisition of Human Genome Sciences, the company with which it co-markets lupus treatment Benlysta.  The …

News

GSK and Theravance file COPD drug

July 16, 2012
Research and Development, Sales and Marketing EMA, GSK, Relovair, Revlar, Spiriva, Theravance

GlaxoSmithKline and US biopharma firm Theravance have submitted their investigational chronic obstructive pulmonary disease (COPD) drug to regulators in Europe …

News
GSK image

GSK launches Olympics drug test adverts

July 16, 2012
Medical Communications, Sales and Marketing GSK, London 2012, Olympics, doping

GlaxoSmithKline has launched a UK advertising campaign to celebrate the role anti-doping science will play in keeping the Games as …

News
Advair image

GSK ruling: Another failing, but will the industry learn?

July 4, 2012
Medical Communications, Sales and Marketing GSK, fraud, legal, marketing fine

Court papers surrounding GSK’s $3 billion fraud charge make for grim reading, and further damages an industry that already struggles …

News

GSK to pay ‘unprecedented’ $3 billion fraud charge

July 3, 2012
Business Services, Sales and Marketing Avandia, Bextra, GSK, Paxil, Wellbutrin, Witty

GlaxoSmithKline will pay $3 billion in fraud charges, the largest of its kind in US history. The charges relate to …

News
GSK image

GSK and Theravance post COPD pill data

July 2, 2012
Research and Development, Sales and Marketing COPD, GSK, LABA, LAMA, Theravance

GSK and partner Theravance have released new data for its combination COPD drug. Results from four late-stage trials suggest that …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025